How should we define STAT3 as an oncogene and as a potential target for therapy?
about
Galiellalactone is a direct inhibitor of the transcription factor STAT3 in prostate cancer cellsUpregulation of TPX2 by STAT3: identification of a novel STAT3 binding site.A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells.MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.STAT3 in Cancer-Friend or Foe?STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia.JAK inhibition and progressive kidney disease.Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma.Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1.Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops.Isocryptotanshinone, a STAT3 inhibitor, induces apoptosis and pro-death autophagy in A549 lung cancer cells.Characterisation of HRas local signal transduction networks using engineered site-specific exchange factors.
P2860
Q33718420-B1BC08BF-955C-4DE0-A77F-2C151CEE5F51Q35424270-23B7DCCF-EFF9-495B-AA50-CCF412D2FA2CQ37022338-0E8AA37C-A316-4819-8A50-77DF31A30524Q37452209-08A5C049-54CD-41E4-BB2C-0DC0C9F39EB2Q37629027-0EC81D72-8E0F-4EFD-BD8A-66AEF100F7E7Q38226313-19FA6CCB-847D-49DA-BD7C-CC1287CFEF05Q38265472-78931570-9989-4DBB-8E06-065B0AD8C7D0Q38270332-076765D7-C1FE-4B3B-A8D8-267AD539505FQ38735599-88034730-574D-4F67-877A-A9098AB12D9BQ38749945-78E00F9C-71CD-4F96-9F55-948248509D75Q38922461-2431A0A3-8A31-40DE-91A3-64DF79CB97E1Q39203633-39EFC6ED-92D4-4BF1-A7CA-5D773DEEEE00Q41915683-8C40F28E-4CF5-4662-B702-CA0D916EA5ABQ48238039-B9F7F266-B074-496A-BF73-D1851288F386
P2860
How should we define STAT3 as an oncogene and as a potential target for therapy?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
How should we define STAT3 as an oncogene and as a potential target for therapy?
@en
type
label
How should we define STAT3 as an oncogene and as a potential target for therapy?
@en
prefLabel
How should we define STAT3 as an oncogene and as a potential target for therapy?
@en
P2093
P2860
P356
P1433
P1476
How should we define STAT3 as an oncogene and as a potential target for therapy?
@en
P2093
Amélie Rébillard
Benjamin Barré
Catherine Guette
Hélène Sellier
P2860
P304
P356
10.4161/JKST.24716
P577
2013-04-16T00:00:00Z